These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 1716974)
21. Two different maturational stages of natural killer lymphocytes in human newborn infants. Sancho L; de la Hera A; Casas J; Vaquer S; Martínez C; Alvarez-Mon M J Pediatr; 1991 Sep; 119(3):446-54. PubMed ID: 1715396 [TBL] [Abstract][Full Text] [Related]
22. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. Carson WE; Giri JG; Lindemann MJ; Linett ML; Ahdieh M; Paxton R; Anderson D; Eisenmann J; Grabstein K; Caligiuri MA J Exp Med; 1994 Oct; 180(4):1395-403. PubMed ID: 7523571 [TBL] [Abstract][Full Text] [Related]
23. Human first-trimester trophoblast cells recruit CD56brightCD16- NK cells into decidua by way of expressing and secreting of CXCL12/stromal cell-derived factor 1. Wu X; Jin LP; Yuan MM; Zhu Y; Wang MY; Li DJ J Immunol; 2005 Jul; 175(1):61-8. PubMed ID: 15972632 [TBL] [Abstract][Full Text] [Related]
24. [Characterization of peripheral blood natural killer (NK) cells in two patients with CD16+ CD56- NK cell-lineage granular lymphocyte-proliferative disorder]. Egashira M; Kaneko T; Oshimi K; Mizoguchi H; Ishida M Rinsho Ketsueki; 1995 Feb; 36(2):69-75. PubMed ID: 7536278 [TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic profiles of peripheral blood lymphocytes on the day of embryo transfer in women undergoing in vitro fertilization. Baczkowski T; Kurzawa R Folia Histochem Cytobiol; 2007; 45 Suppl 1():S73-7. PubMed ID: 18292839 [TBL] [Abstract][Full Text] [Related]
26. Glycodelin-A stimulates the conversion of human peripheral blood CD16-CD56bright NK cell to a decidual NK cell-like phenotype. Lee CL; Vijayan M; Wang X; Lam KKW; Koistinen H; Seppala M; Li RHW; Ng EHY; Yeung WSB; Chiu PCN Hum Reprod; 2019 Apr; 34(4):689-701. PubMed ID: 30597092 [TBL] [Abstract][Full Text] [Related]
28. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells. Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954 [TBL] [Abstract][Full Text] [Related]
29. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. Caligiuri MA; Murray C; Robertson MJ; Wang E; Cochran K; Cameron C; Schow P; Ross ME; Klumpp TR; Soiffer RJ J Clin Invest; 1993 Jan; 91(1):123-32. PubMed ID: 7678599 [TBL] [Abstract][Full Text] [Related]
30. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand. Carson WE; Fehniger TA; Caligiuri MA Eur J Immunol; 1997 Feb; 27(2):354-60. PubMed ID: 9045904 [TBL] [Abstract][Full Text] [Related]
31. NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1. Keever CA; Pekle K; Gazzola MV; Collins NH; Gillio A Cell Immunol; 1990 Mar; 126(1):211-26. PubMed ID: 1689220 [TBL] [Abstract][Full Text] [Related]
32. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. Naume B; Gately M; Espevik T J Immunol; 1992 Apr; 148(8):2429-36. PubMed ID: 1373169 [TBL] [Abstract][Full Text] [Related]
33. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872 [TBL] [Abstract][Full Text] [Related]
34. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211 [TBL] [Abstract][Full Text] [Related]
35. Decidual stromal cells promote the differentiation of CD56 Yang HL; Zhou WJ; Lu H; Lei ST; Ha SY; Lai ZZ; Zheng ZM; Ruan LY; He YY; Li DJ; Li MQ; Shao J Am J Reprod Immunol; 2019 Jun; 81(6):e13110. PubMed ID: 30903677 [TBL] [Abstract][Full Text] [Related]
36. Cell populations in the human early pregnancy decidua: natural killer activity and response to interleukin-2 of CD56-positive large granular lymphocytes. Ferry BL; Starkey PM; Sargent IL; Watt GM; Jackson M; Redman CW Immunology; 1990 Aug; 70(4):446-52. PubMed ID: 1697563 [TBL] [Abstract][Full Text] [Related]
37. Human fetal liver-derived CD7+CD2lowCD3-CD56- clones that express CD3 gamma, delta, and epsilon and proliferate in response to interleukin-2 (IL-2), IL-3, IL-4, or IL-7: implications for the relationship between T and natural killer cells. Hori T; Phillips JH; Duncan B; Lanier LL; Spits H Blood; 1992 Sep; 80(5):1270-8. PubMed ID: 1381242 [TBL] [Abstract][Full Text] [Related]
38. Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: the FcR gamma III (CD16) molecule and NK cell differentiation. Warren HS; Skipsey LJ Immunology; 1991 Jan; 72(1):150-7. PubMed ID: 1825480 [TBL] [Abstract][Full Text] [Related]
39. Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases. Borrego F; Peña J; Solana R Eur J Immunol; 1993 May; 23(5):1039-43. PubMed ID: 8477800 [TBL] [Abstract][Full Text] [Related]
40. Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. Saito S; Nishikawa K; Morii T; Enomoto M; Narita N; Motoyoshi K; Ichijo M Int Immunol; 1993 May; 5(5):559-63. PubMed ID: 7686393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]